Biomedical biopolymers, their origin and evolution in biomedical sciences: A systematic review

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 9, 2015, Pages 21-25

  Yadav, Preeti ^a   Yadav, Harsh ^b   Shah, Veena Gowri ^a   Shah, Gaurav ^a   Dhaka, Gaurav ^b  

^a NIMS UNIVERSITY   (India)

^b Oral and Maxillofacial Surgery ^*  (India)

Author keywords

Biodegradable; Biomedical applications; Polymers

Indexed keywords

BIOPOLYMER; CARRAGEENAN; CELLULOSE; CHITOSAN; COLLAGEN; GELATIN; GUM ARABIC; HYALURONIC ACID; PECTIN; XANTHAN; XYLAN;

ANTIGENICITY; BIOCOMPATIBILITY; BIODEGRADATION; BIOLOGICAL ACTIVITY; CELL GROWTH; CELL PROLIFERATION; DRUG DELIVERY SYSTEM; HUMAN; MEDICAL TECHNOLOGY; POROSITY; REVIEW; SYSTEMATIC REVIEW; TISSUE ENGINEERING; WOUND HEALING;

EID: 84941368370     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/13907.6565     Document Type: Review

References (94)

1. Pakawadee Kaewkannetra. Fermentation of Sweet Sorghum into Added Value Biopolymer of Polyhydroxyalkanoates (PHAs). In: Casparus Johannes Reinhard Verbeek editor. Products and Applications of Biopolymers. Croatia: Intech; 2012. pp. 41-60.
2. Kaplan DL, et al. ‘Naturally Occurring Biodegradable Polymers’ G Swift and R Narayan (eds). Polymer. Systems-Synthesis and Utility. New York: NY Hanser Publishing; 1994.
3. Ramesh Babu NG, Anitha N, Hema Kalai Rani R. Recent Trends in Biodegradable Products from Biopolymers. Advanced Biotech. 2010;9(11):30-34.
4. Gross AR, Kalra B. Biodegradable Polymers for the Environment. Sci. 2002;297:803-07.
5. Harkness RD. Biological functions of collagen. Biol Rev. 1961;36:399–463.
6. Lee CH, Singla A, Lee Y. Biomedical applications of collagen. Int J Pharmaceut. 2001;221:1–22.
7. Friess W. Collagen-biomaterial for drug delivery. Eur J Pharm Biopharm. 1998;45:113–36.
8. Maeda M, Tani S, Sano A, Fujioka K. Microstructure and release characteristics of the minipellet, a collagen based drug delivery system for controlled release of protein drugs. J Controlled Rel. 1999;62:313–24.
9. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release. 1999;59:299–307.
10. Berthold A, Cremer K, Kreuter J. Collagen microparticles: carriers for glucocorticosteroids. Eur J Pharm Biopharm. 1998;45:23–29.
11. Morrison NA, Clark RC, Chen YL, Talashek T, Sworn G. Gelatin alternatives for the food industry. Progr Colloid Polym Sci. 1999;114:127-31.
12. Mariod AA, Adam HF. Review: gelatin, source, extraction and industrial applications. Acta Sci Pol Technol Aliment. 2013;12(2):135-47.
13. Lobo L. Coalescence during emulsification. 3. Effect of gelatin on rupture and coalescence. J Coll Interface Sci. 2002;254:165-74.
14. Domard A, Domard M. Chitosan: Structure properties relationship and biomedical applications. Polym Biomater. 2002;9:187–212.
15. Canella KMNC, Garcia RB. Caracterização de quitosana por cromatografia de permeação em gel. Influência do método de preparação e do solvente. Quim Nova. 2001;24(1):13-17.
16. Signini R. Estudo das relações estruturas/propriedades de quitina e quitosana. Tese (Doutorado em Físico-Química). Instituto de Química de São Carlos-USP-São Paulo 2002.
17. Synowiecki J, Al-Khatteb NAA. Production, properties, and some new applications of chitin and its derivatives. Crit Rev Food Sci Nut. 2003;43:144-71.
18. Hamman JH. Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery Systems. Mar Drugs. 2010;8:1305-22.
19. Kong M, Chen XG, Xing K, Park HJ. Antimicrobial properties of chitosan and mode of action: A state of the art review. Int J Food Microbiol. 2010;144:51–63.
20. Feng Y, Xia W. Preparation, characterization and antibacterial activity of water-soluble O-fumaryl-chitosan. Carbohyd Polym. 2011;83:1169–73.
21. Sano H, Shibasaki R, Matsukubo T, Takaesu Y. Effect of chitosan rinsing on reduction of dental plaque formation. Bull Tokyo Dent Coll. 2003;44:9-16.
22. Stamford-Arnaud TM, Barros-Neto B, Diniz FB. Chitosan effect on dental enamel de-remineralization: An invitro evaluation. J Dent. 2010;38:848-52.
23. Murugan R, Ramakrishna S. Bioresorbable composite bone paste using polysaccharide based nano hydroxyapatite. Biomaterials. 2004;25:3829-35.
24. Tanodekaew S, Prasitsilp M, Swasdison S, Thavornyutikarn B, Pothsree, Pateepasen R. Preparation of acrylic grafted chitin for wound dressing application. Biomaterials. 2004;25:1453-60.
25. Maia RCC, Franco LO, Stamford TCM, Fukushima K, Porto ALF, Campos-Takaki GM. Chitin produced by Cunninghamella elegans (IFM 46109) and applied to wound healing. Asian Chitin Journal. 2006;2:11-20.
26. Mori T, Murakami M, Okumura M, Kadosawa T, Uede T, Fujinaga T. Mechanism of macrophage activation by chitin derivatives. J Vet Med Sci. 2005;67:51–56.
27. Anraku M, Kabashima M, Namura H, Maruyama T, Otagiri M, Gebicki J, et al. Antioxidant protection of human serum albumin by chitosan. Int J Biol Macromol. 2008;43:159–64.
28. Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev. 2001;52:105–15.
29. Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials. 2003;24:2133–51.
30. Iwata H, Yana S, Nasu M, Yosue T. Effects of chitosan oligosaccharides on the femur trabecular structure in ovariectomized rats. Oral Radiol. 2005;21:19–22.
31. Porporatto C, Canali MM, Bianco ID, Correa SG. The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen. Clin Exp Immunol. 2009;155:79–87.
32. Murakami K, Aoki H, Nakamura S, Nakamura SI, Takikawa M, Hanzawa MM, et al. Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing impaired wound dressings. Biomaterials. 2010;31:83–90.
33. Di Martino A, Sittinger M, Risbud MV. Chitosan: A versatile biopolymer for orthopedic tissue-engineering. Biomaterials. 2005;26:5983–90.
34. Francis Suh J, Matthew H. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials. 2000;21: 2589-98.
35. Hu Q, Li B, Wang M, Shen J. Preparation and characterization of biodegradable chitosan/hydroxyapatite nanocomposite rods via in situ hybridization: a potential material as internal fixation of bone fracture. Biomaterials. 2004;25:779–85.
36. Xia W, Liu P, Zhang J, Chen J. Biological activities of chitosan and chitooligosaccharides. Food Hydrocolloids. 2011;25:170-79.
37. Yadav AV, Bhise B. Chitosan: a potential biomaterial effective against typhoid. Cur Sci. 2004;87(9):1176-78.
38. Rios JL, Recio MC. Medicinal plants and antimicrobial activity. J Ethnopharmacol. 2005;100(1-2):80-84.
39. Muzzarelli T, Pruzzo G. Inhibition of Streptococcus mutans adsorption to hydroxyapatite by low-molecular-weight chitosans. Oral Microbiol Immun. 1997;72:665-72.
40. Yoshiharu N, Paul L, Henri C. Crystal Structure and Hydrogen-Bonding System in Cellulose Iβ from Synchrotron X-ray and Neutron Fiber Diffraction. J Am Chem Soc. 2002;124(31):9074–82.
41. Tomsic B, Simoncic B, Orel B, Vilcnik A, Spreizer H. Biodegradability of cellulose fabric modified by imidazolidinone. Carbohydr Polym. 2007;69(3):478-88.
42. Peppas NA. Hydrogels and drug delivery. Curr Opin Colloid Interface Sci. 1997;2(5):531-57.
43. Drury JL, Mooney DJ. Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials. 2003;24(24):4337-51.
44. Entcheva E, Bien H, Yin L, Chung CY, Farrell M, Kostov Y. Functional cardiac cell constructs on cellulose-based scaffolding. Biomaterials. 2004;25(26):5753-62.
45. Stabenfeldt SE, Garcia AJ, LaPlaca MC. Thermoreversible laminin-functionalized hydrogel for neural tissue engineering. J Biomed Mater Res A. 2006;77(4):718-25.
46. Svensson A, Nicklasson E, Harrah T, Panilaitis B, Kaplan DL, Brittberg M, et al. Bacterial cellulose as a potential scaffold for tissue engineering of cartilage. Biomaterials. 2005;26(4):419-31.
47. Czaja WK, Young DJ, Kawecki M, Malcolm Brown R. The future prospects of microbial cellulose in biomedical applications. Biomacromolecules. 2007;8(1): 1-12.
48. Ebringerova A, Heinze T. Xylan and xylan derivatives iopolymers with valuable properties, 1–Naturally occurring xylans: structures, isolation, procedures and properties. Macromol Rapid Comm. 2000;21(9):542-56.
49. Kayserilioglu BS, Bakir U, Yilmaz L, Akkas N. Use of xylan, an agricultural by-product, in wheat gluten based biodegradable films: mechanical, solubility and water vapor transfer rate properties. Bioresour Technol. 2003;87(3):239-46.
50. Kacurakova M, Capek P, Sasinkova V, Wellner N, Ebringerova A. FT-IR study of plant cell wall model compounds: Pectic polysaccharides and hemicelluloses. Carbohydr Polym. 2000;43(2):195-203.
51. Oliveira EE, Silva AE, Nagashima Jr T, Gomes M CS, Aguiar LM, Marcelino HR, et al. Xylan from corn cobs, a promising polymer for drug delivery: Production and characterization. Bioresour Technol. 2010;101(14):5402-06.
52. Saha BC. Alpha-L-arabinofuranosidases: Biochemistry, molecular biology and application in biotechnology. Biotechnol Adv. 2000;18(5):403-23.
53. Ebringerova A, Hromadkova Z. Xylans of industrial and biomedical importance. Biotechnology and Genetic Engineering Reviews. 1999;16:325-46.
54. Narayanan RP, Melman G, Letourneau NJ, Mendelson NL, Melman A. Photodegradable iron (III) cross-linked alginate gels. Biomacromolecules. 2012; 13:2465-71.
55. Bouhadir KH, Lee KY, Alsberg E, Damm KL, Anderson KW, Mooney DJ. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog. 2001;17:945–50.
56. Kong HJ, Alsberg E, Kaigler D, Lee KY, Mooney DJ. Controlling degradation of hydrogel via the size of cross-linked junctions. Adv Mater. 2004;16:1917–21.
57. Balakrishnan B, Jayakrishnan A. Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds. Biomaterials. 2005;26:3941–51.
58. Gaserod O, Smidsrod O, Skjak-Braek G. Microcapsules of alginate-chitosan I: A quantitative study of the interaction between alginate and chitosan. Biomaterials. 1998;19:1815–25.
59. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials. 1999;20:45–53.
60. Richards AJ, Hagelstein SM, Patel GK, Ivins NM, Sweetland HM, Harding KG. Early use of negative pressure therapy in combination with silver dressings in a difficult breast abscess. Int Wound J. 2011;8(6):608–11.
61. Opanson S, Magnette A, Meuleneire F, Harding K. Askina® Calgitrol® Made easy. Wounds Int. 2012;3(1).
62. Chrisman CA. Care of chronic wounds in palliative care and end-of-life patients. Int Wound J. 2010;7(4):214–35.
63. Li X, Chen S, Zhang B, Li M, Diao K, Zhang Z, et al. In situ injectable nano-composite hydrogel composed of curcumin, N, O-carboxymethyl chitosan and oxidized alginate for wound healing application. Int J Pharm. 2012;437:110–19.
64. Hooper SJ, Percival SL, Hill KE, Thomas DW, Hayes AJ, Williams DW. The visualization and speed of kill of wound isolates on a silver alginate dressing. Int Wound J. 2012;9:633–42.
65. Cao Y, Shen XC, Chen Y, Guo J, Chen Q, Jiang XQ. pH-Induced self-assembly and capsules of sodium alginate. Biomacromolecules. 2005;6:2189–96.
66. Mi FL, Shyu SS, Linc YM, Wuc YB, Peng CK, Tsai YH. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: A new delivery system for protein. Biomaterials. 2003;24:5023–36.
67. Abbah SA, Liu J, Lam RW, Goh JC, Wong HK. Invitro bioactivity of rhBMP-2 delivered with novel polyelectrolyte complexation shells assembled on an alginate microbead core template. J Control Rel. 2012;162: 364–72.
68. Zhao Q, Mao Z, Gao C, Shen J. Assembly of multilayer microcapsules on CaCO3 particles from biocompatible polysaccharides. J Biomater Sci Polym Ed. 2006;17:997–1014.
69. Marchetti M, Pisani S, Pietropaolo V, Seganti L, Nicoletti R, Orsi N. Inhibition of herpes simplex virus infection by negatively charged and neutral carbohydrate polymers. J Chemotherapy. 1995;7:90–96.
70. Carlucci MJ, Scolaro LA, Damonte EB. Inhibitory action of natural carrageenans on herpes simplex virus infection of mouse astrocytes. Chemotherapy. 1999;45:429–36.
71. Buck ChB, Thompson CD, Roberts JN, Muller M, Lowy DR, Schiller JT. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog. 2006;2:0671–80.
72. Lev R, Long R, Mallonga L, Schnaram R, Reily W. Evaluation of Carrageenan as Base for Topical Gels. Pharm Res. 1997;14:42.
73. Lui Y, Schnaram R, Reily W. Evaluation of Carrageenan as Suppository Base. Pharm Res. 1997;14:41.
74. Clark DT, Gazi MI, Cox SW, Eley BM, Tinsley GF. The effects of Acacia arabica gum on the invitro growth and protease activities of periodontopathic bacteria. J Clin Periodontol. 1993;20(4):238–43.
75. Onishi T, Umemura S, Yanagawa M, Matsumura M, Sasaki Y, Ogasawara T, et al. Remineralization effects of gum arabic on caries-like enamel lesions. Arch Oral Biol. 2008;53(3):257-60.
76. Kenneth J Anusavice. (2003): Gypsum products; in Phillips’ Science of Dental Materials. 11th edition. St. Louis, Missouri: Elsevier. pp. 258.
77. Sharma BR, Naresh L, Dhuldhoya NC, Merchant SU, Merchant UC. Xanthan Gum—A Boon to Food Industry. Food Promot Chron. 2006;1:27-30.
78. Garcõ Âa-Ochoa F, et al. Xanthan gum: production, recovery, and properties. Biotechnol Adv. 2000;18:549-79.
79. Katzbauer B. Properties and Applications of Xanthan Gum. Polym Degrad Stabil. 1998;59:81-84.
80. Mukhiddinov ZK, et al. Isolation and structural characterization of a pectin homo and ramnogalacturonan. Talanta. 2000;53:171-76.
81. Wang NL, Kiyohara H, Matsumoto T, Otsuka H, Hirano M, Yamada H. Polyclonal antibody against a complement-activating pectin from the roots of Angelica acutiloba. Planta Med. 1994;60:425–29.
82. Michaelsen TE, Gilje A, Samuelsen AB, Høgåsen K, Paulsen BS. Interaction between human complement and a pectin type polysaccharide fraction, PMII, from the leaves of Plantago major L. Scand J Immunol. 2000;52:483-90.
83. Chen CH, Sheu MT, Chen TF, Wang YC, Hou WC, Liu DZ. Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways. Biochem Pharmacol. 2006;72: 1001–09.
84. Salman H, Bergman M, Djaldetti M, Orlin J, Bessler H. Citrus pectin affects cytokine production by human peripheral blood mononuclear cells. Biomed Pharmacother. 2008;62:579–82.
85. Ito T, Iida-Tanaka N, Koyama Y. Efficient in vivo Gene Transfection by Stable DNA/ PEI Complexes Coated by Hyaluronic Acid. J Drug Target. 2008;16:276-81.
86. Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic Drug Delivery Systems—Recent Advances. Prog Retin Eye Res. 1998;17:33-58.
87. Bucolo C, Mangiafico S, Spadaro A. Methylprednisolone Delivery by Hyalobend Corneal Shields and Its Effects on Rabbit Ocular Inflammation. J Ocul Pharmacol Ther. 1996;12:141-49.
88. Price RD, Berry MG, Navsaria HA. Hyaluronic Acid: The Scientific and Clinical Evidence. J Plast Reconstruct Aesth Surg. 2007;60:1110-19.
89. McDonald CC, Kaye SB, Figueiredo FC, Macintosh G, Lockett C. A Randomized, Crossover, Multicenter Study to Compare the Performance of 0.1% (w/v) Sodium Hyaluronate with 1.4% (w/v) Polyvinyl Alcohol in the Alleviation of Symptoms Associated with Dry Eye Syndrome. Eye. 2002;16:601-07.
90. Aragona P, Di Stefano G, Ferreri F, Spinella R, Stilo A. Sodium Hyaluronate Eye Drops of Different Osmolarity for the Treatment of Dry Eye in Sjogren’s Syndrome Patients. Br J Ophthalmol. 2002;86:879-84.
91. Bray BA. The Role of Hyaluronan in the Pulmonary Alveolus. J Theor Biol. 2001;210:121-30.
92. Uthman I, Raynauld JP, Haraoui B. Intra-articular therapy in osteoarthritis. Postgrad Med J. 2003;79:449–53.
93. Leach JB, Schmidt CE. Hyaluronan. Encyclopedia of Biomaterials and Biomedical Engineering. Marcel Dekker, New York. 2004; 779–789.
94. Dechert TA, Ducale AE, Ward SI, Yager DR. Hyaluronan in human acute and chronic dermal wounds. Wound Repair Regen. 2006;14:252–58.